Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NTRBW | US
-0.18
-14.63%
Healthcare
Biotechnology
31/07/2024
18/10/2024
1.05
1.23
1.23
1.05
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated in 2016 and is headquartered in Orlando Florida.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
263.9%1 month
272.0%3 months
291.3%6 months
278.2%-
-
-
0.02
0.02
-
-
-
-5.46M
-
-
-
-462.50
-
-14.30
-60.41
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.00
Range1M
1.03
Range3M
2.67
Rel. volume
0.36
Price X volume
1.02K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
UroGen Pharma Ltd | URGN | Biotechnology | 12.73 | 0 | -0.86% | n/a | 326.69% |
Unicycive Therapeutics Inc. Common Stock | UNCY | Biotechnology | 0.429 | 0 | -5.69% | n/a | -315.38% |
Unity Biotechnology Inc | UBX | Biotechnology | 1.4 | 0 | 1.45% | n/a | 109.64% |
SABSW | SABSW | Biotechnology | 0.0492 | 0 | 4.02% | 0.17 | 11.58% |
Revolution Medicines Inc. Warrant | RVMDW | Biotechnology | 0.101 | 0 | 0.00% | n/a | 5.40% |
REVBW | REVBW | Biotechnology | 0.0133 | 0 | -0.75% | n/a | 0.00% |
Rocket Pharmaceuticals Inc. Warrant | RCKTW | Biotechnology | 0.0709 | 0 | 14.35% | n/a | 0.00% |
OCEAW | OCEAW | Biotechnology | 0.0388 | 0 | -3.00% | n/a | -16.02% |
NKGen Biotech Inc. Warrants | NKGNW | Biotechnology | 0.0248 | 0 | -58.67% | n/a | -40.33% |
Pasithea Therapeutics Corp. Warrant | KTTAW | Biotechnology | 0.0275 | 0 | 27.91% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Urban One Inc | UONEK | Broadcasting - Radio | 1.045 | 0 | -2.34% | n/a | 268.43% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.38 | 0 | 0.37% | 22.53 | 56.33% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 3.92 | 0 | -8.84% | n/a | 0.00% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.4801 | 0 | -10.26% | n/a | 19.98% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.82 | 0 | 1.93% | 9.09 | 39.79% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | - | 0.53 | - |
Ent. to Revenue | - | 3,967.00 | - |
PE Ratio | - | 41.03 | - |
Price to Book | - | 15.55 | - |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 291.25 | 72.80 | Riskier |
Debt to Equity | 0.02 | -1.23 | Expensive |
Debt to Assets | 0.02 | 0.25 | Cheaper |
Market Cap | - | 3.66B | - |